These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21191666)

  • 1. Cutting edge issues in polymyositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Gorza L; Doria A
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):179-89. PubMed ID: 21191666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies in polymyositis and dermatomyositis.
    Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
    Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myositis-specific autoantibodies and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of myositis specific autoantigens during post-natal myogenesis.
    Zampieri S; Biral D; Adami N; Ghirardello A; Rampudda ME; Tonello M; Doria A
    Neurol Res; 2008 Mar; 30(2):145-8. PubMed ID: 18397605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.
    Gunawardena H; Betteridge ZE; McHugh NJ
    Rheumatology (Oxford); 2009 Jun; 48(6):607-12. PubMed ID: 19439503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody Specificity.
    Pinal-Fernandez I; Amici DR; Parks CA; Derfoul A; Casal-Dominguez M; Pak K; Yeker R; Plotz P; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Corse AM; Lloyd TE; Christopher-Stine L; Mammen AL
    Arthritis Rheumatol; 2019 Aug; 71(8):1371-1376. PubMed ID: 30861336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
    Haq SA; Tournadre A
    Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK
    Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immunity in polymyositis/dermatomyositis.
    Targoff IN
    J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies: Pathogenic or epiphenomenon.
    Galindo-Feria AS; Wang G; Lundberg IE
    Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101767. PubMed ID: 35810122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type I interferon system in idiopathic inflammatory myopathies.
    Lundberg IE; Helmers SB
    Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.